Company / PP&E per Share
GYRE THERAPEUTICS, INC. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.27
FY2025
5-year range
$0.04 / $0.37
FY2021-FY2025
Trend
-12.3%
vs FY2024
Sector context
#73 of 191
Health Care
What the data says
At $0.27, GYRE THERAPEUTICS, INC.'s pp&e per share ranks #73 of 191 in the Health Care sector. Declined from $0.37 to $0.27 over the past 2 years.
Based on SEC 10-K filings.
0.27 in FY2025 with a 5-year CAGR of +50.0%.
Declined from $0.37 to $0.27 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +5.3%
- 5-Year CAGR
- +50.0%
- 10-Year CAGR
- -
Sector benchmark
#73 of 191 in Health CareTop 38% of 191This company $0.27 Sector average $18.90
▼
-98.6% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 12.3% year-over-year.
- Ranks #73 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2016.
- Lowest pp&e per share in the period was in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.27 | -12.3% |
| FY2024 | $0.31 | -14.9% |
| FY2023 | $0.37 | +56.5% |
| FY2022 | $0.23 | +433.0% |
| FY2021 | $0.04 | +22.1% |
| FY2020 | $0.04 | +41.4% |
| FY2019 | $0.03 | -59.9% |
| FY2018 | $0.06 | -21.3% |
| FY2017 | $0.08 | -85.9% |
| FY2016 | $0.57 | -75.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026